959-107 Outcome of In-hospital Cardiopulmonary Resuscitation  by de Vas, Rien et al.
212A ABSTRACfS JACC February 1995
CHF/Cardiac nonCHF/Cardiac noncardiac
N 30 26 90
Age 63 (4971) 67 (6072) 63(2971)
Sex (% male) 37 58 60
Initial Rhythm N(%)
vrNF 7 (25) 11 (44) 24 (27)
Asystole 6 (21.4) 6(24) 33 (37.5)
Bradycardia 5 (17.9) 2 (8) 6(6.8)
EMD 6 (21.4) 1(4) 13(148)
Other 4 (14.3) 5 (20) 12(136)
ROSC 21 (70) 13 (50) 51 (567)
Survival to D/C 1(3.3) 4 (15.4) 2 (2.2)
Results: group A group B
ATP-tested yes no
patients (n) 18 48
VT episodes 532 491
ATP-termination 468 430
ATP unsuccessfull 29 41
VT-acceleration 35(6.6%) 20 (4.7%)
AlP-success rate 88% 88%
Conclusion: The autodecremental ramp is a safe and effective antitachy-
cardia pacing mode for terminating spontaneous ventricular tachycardias in
88% regardless of the result of the pre-discharge test.
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Patients with nonCHF/Cardiac disease had a higher ROSC than patients
with CHF and noncardiac diseases (p = 0.016). In summary, patients with
CHF often experience cardiopulmonary arrest with bradycardic or EMD ar-
rests. Although patients with CHF are resuscitated with a high degree of suc-
cess their in-hospital survival was low. Furthermore, the high rate of brady-
cardic and EMD arrests may explain the low in-hospital survival rates.
Implantation of a Single-Lead Unipolar
Transvenous Cardioverter/Defibrillatior (ICD)
Under Local Anesthesia
Therapy A B C D global p
PCl/No B 91/7 81/7 91/15 81/15
Allvr 68% 46% 85% 61% 69% <0.001
VTCL < 350· 82% 14% 44% 38% 47% 0.03
VTCl> 350 73% 100% 91% 86% 90% ns
Burst antitachycardia pacing (ATP) is higly efficacious for termination
of monomorphic ventricular tachycardia (MVT). Since several pacing se-
quences are usually programmed as a single therapy. optimal programming
is presently unknown. In 40 patients (P) with MVT and a 3rd generation AICD,
4 burst ATP were prospectively compared (as a first single ATP) during follow-
up in a randomized design crossing over every 2-3 months. Burst ATP modes
(A to D) were defined by pacing cycle length (PCl, as % of VTCl) and num-
ber of beats (No B) (Table). A second ATP zone was programmed in a non
selected way in all patients.
Results (Table): 374 episodes (317 considered MVT) received ATP thera-
pies in 23 patients. RR intervals could be retrieved for MVT-Cl analysis in
168 episodes. Succes rate of combined first (randomized) and second (non
selected) therapies was 92%. Acceleration rate estimation was 2%.
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The purpose of this study was to prospectively evaluate single-lead unipolar
transvenous ICD implantation under local anesthesia and defibrillator thresh-
old testing under mild sedation.
In 12 consecutive patients (mean age. 61 ± 10 years) transvenous ICD im-
plantation was performed (9 patients had ischemic heart disease. 3 patients
dilated cardiomyopathy). The presenting arrhythmia was ventricular fibrilla-
tion in 4 patients. and monomorphic ventricular tachycardia in 8 patients.
Mean lVEF was 26 ± 11 %. A single-lead unipolar transvenous ICD with
biphasic defibrillation pulse was implanted subpectorally in all patients un-
der local anesthesia with 1% lidocaine. During defibrillation threshold (OFT)
testing sedation was applied with 11.5 ± 5.1 mg (0.14 ± 0.05 mglkg) mi-
dazolam. For DFT determination 5.8 ± 1.3 episodes of ventricular fibrillation
(mean total ventricular fibrillation time 52.4 ± 14.7 seconds) were induced.
Mean OFT was 12.8 ± 4.3 J. mean duration of the implantation procedure
was 58 ± 13 minutes. Heart rate. mean arterial blood pressure. and arterial
oxygen saturation were not significantly different before and after DFT deter-
mination. One patient had moderate pain during DFT testing. and 3 patients
had mild pain during the surgical procedure. Symptoms during the proce-
dure were evaluated using a standardized questionnaire. Severe feeling of
panic and surprise, and discomfort of moderate degree was reported by 2
patients. There were no complications. Hospital length of stay: all patients
were discharged on the second postoperative day. Postimplant ICD testing
was performed successfully without sedation 35 ± 1.4 days after ICD im-
plantation, in 6 patients as an outpatient procedure.
Conclusions: Single-lead unipolar transvenous ICD systems can safely
be implanted under local anesthesia and mild sedation during defibrillation
threshold testing. The procedure is well tolerated.
• Cl < 350: group of Mvr with Cl < 350 ms. 0 Cl > 350: Mvr with Cl > 350 ms
Conclusions: 1. Efficacy of the tested burst pacing modes differs signifi-
cantly, at least in fast VT. 2. Contrary to what could be expected. "less agres-
sive" bursts seem to be more efficacious, even in fast VT.
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Cerebral and overall performance after successful resuscitation is an impor-
tant measure of its success. To evaluate resuscitation attempts in adults (age
:0: 18 years) by the 24-hrs resuscitation team in our hospital (1,032 beds;
27,500 admissions/years), we prospectively collected data from resuscita-
tion forms and retrospectively from medical records. Performance was as-
sessed retrospectively by means of the Cerebral and Overall Performance
Categories (CPC/OPC).
Results: A total of 1205 calls were received from June 1988 up to Jan-
uary 1994 (the emergency room and general wards always call upon the
team, CCU/ICU only when intubation is required). 717/1205 calls were con-
firmed arrests in 675 adults (mean age 58, 43% >70 years). Resuscitation
was not attempted in 10 arrests. Return of spontaneous circulation occurred
in 347/717 arrests (49%). followed by transfer to the ICU or CCU. Of the 347
initial survivors 93 (27%) died within 24 hrs. and another 138 (40%) died later
during their hospital stay. 101 (15%) pts (38% > 70 years) were discharged
from the hospital alive. VFNT as initial rhythm was present in 60 (60%) sur-
vivors and ischaemic heart disease (ICD 41 0-414)was diagnosed in 40 (40%)
survivors.
Outcome performance was assessed at the time of discharge. Good
outcome: CPC1, 90 pts (90%); OPC1, 78 (78%); Moderate disabilities:
CPC2. 4 pts (4%); OPC2, 14 pts (14%); Severely disabledlvegetative state:
CPC/OPC3-4, 7 pts (7%). A total of 36 pts (36%) died after discharge. of
which 19 (53%) died within the first year.
Conclusion: Survivors after of in-hospital circulatory arrest have a good
prognosis in terms of cerebral and overall performance, but long term suc-
cesses are limited.
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The value of testing antitachycardia pacing (ATP) for the termination of
ventricular tachycardias (VT) in implantable defibrillators was evaluated in
a prospective trial. Pre-discharge testing of antitachycardia pacing was
attempted in 66 consecutive patients (pts) with non-thoracotomy third-
generation implantable cardioverter-defibrillators (ICD). VT's could be in-
duced in 18 pts (group A: 14 CAD, 3 DCM. 1 other) and were terminated
by ATP at the pre-discharge testing at least twice. In 48 pts (group B: 30
CAD,9 DCM, 9 others) the effectivity of ATP could not be tested due to non-
inducible VT ATP was programmed in both groups as an autodecremental
ramp with 81 % of the tachycardia cycle length and up to 4 sequences with
8 to 11 stimuli. The mean follow-up was 10 months
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